Iparomlimab and Tuvonralimab With Chemoradiation for the Treatment of Locally Recurrent and Oligometastatic Cervical Cancer
Shandong Cancer Hospital and Institute
Shandong Cancer Hospital and Institute
Loyola University
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)
University of Utah
University of Alabama at Birmingham
Northwestern University